CD4 News and Research

RSS

Scientists cure advanced skin cancer with body's own cells

Scientists in the U.S. are claiming they have cured advanced skin cancer by using the patient's own cells.

19 Jun 2008

Without increased funding, California's dominance and public health are threatened, according to new report

The California Healthcare Institute (CHI) and PricewaterhouseCoopers (PwC) today released a report, "The National Institutes of Health: Fueling Healthcare Innovation in California," urging legislators to support increased funding for the National Institutes of Health (NIH) - the backbone of the biomedical industry in California, which employs more than 267,000 people in high wage jobs.

11 Jun 2008

Possible biological explanation for C-Section-linked allergies and asthma found

Scientists believe they may have identified a biological explanation for the link between cesarean-section delivery and risk of allergy and asthma in childhood. They will present their findings at the American Thoracic Society's 2008 International Conference in Toronto on Tuesday, May 20.

21 May 2008

Farming mothers may help children beat allergies

Mothers exposed to farms, particularly to barns and farm milk, while pregnant confer protection from allergies on their newborns, according to a group of German researchers, who will present their findings at the American Thoracic Society's 2008 International Conference in Toronto on Wednesday, May 21.

20 May 2008

Blood-free monitoring as good as blood tests in predicting the course of AIDS

Researchers at the University of Pennsylvania School of Medicine have shown that monitoring treatment adherence to AIDS therapy is a simple blood-free way to monitor risk of disease progression. The international study was published in the May issue of the journal PLoS Medicine.

20 May 2008

Monitoring whether patients take medicines can help anticipate HIV treatment failure in Africa

Information on how reliably people take their anti-HIV medicines can help identify those whose treatment will succeed or fail. Monitoring this information, which can be obtained directly from pharmacy records, works at least as well as performing blood tests that track the medicine's effect on the immune system, according to research published in PLoS Medicine by Gregory Bisson, Jean Nachega and colleagues at the University of Pennsylvania, Johns Hopkins Bloomberg School of Public Health, and the University of Cape Town.

20 May 2008

Researchers discover 'reservoir' that allows HIV to remain infectious despite treatment

Researchers at Brigham Young University and the Johns Hopkins School of Medicine have discovered a human cell "reservoir," called follicular dendritic cells, that allows HIV to stay in an infectious state and not respond to antiretroviral drugs, the Deseret Morning News reports.

19 May 2008

GeoVax Labs to launch phase II trials of HIV vaccine candidate

The Atlanta-based biotechnology firm GeoVax Labs plans to launch Phase II clinical trials of its experimental HIV vaccine this summer, company officials recently announced, the Atlanta Journal-Constitution reports (Hendrick, Atlanta Journal-Constitution, 5/8).

8 May 2008

Tests monitoring viral loads, CD4+ count do not significantly affect survival rates among HIV-positive people

Survival rates among HIV-positive people who undergo routine viral load and CD4+ T cell counts were nearly the same as those who do not receive the tests, according to a study published on Friday in the journal Lancet, the CP/Google.com reports (CP/Google.com, 4/24).

28 Apr 2008

Monitoring AIDS treatment by physical symptoms is effective

When millions of HIV-infected people in poor countries began receiving advanced drug therapies, critics worried that patient care would suffer because few high-tech laboratories were available to guide treatments.

24 Apr 2008

Zimbabwe HIV/AIDS Union calls on groups to provide post-testing services

The Zimbabwe HIV and AIDS Activist Union recently called on organizations involved in the fight against the disease to stop offering HIV tests if they cannot provide post-testing services, the Herald/AllAfrica.com reports.

22 Apr 2008

T-cell multiplication unexpectedly delayed after infection

In a surprising outcome that overturns the conventional wisdom on the body's immune response to infection, scientists at The Scripps Research Institute have shown that T cells do not begin proliferation until up to three days after infection.

11 Apr 2008

Roswell Park Cancer Institute awarded three-years funding for ovarian cancer vaccine

The Ovarian Cancer Research Fund has awarded a $900,000 research grant to Kunle Odunsi, MD, Department of Gynecologic Oncology, and his colleagues at Roswell Park Cancer Institute (RPCI) to collaborate on developing a promising vaccine to unleash the power of the immune system against cancer.

7 Apr 2008

Genetic mutations tied to immune comeback during therapy for HIV-1

Researchers with the Infectious Disease Clinical Research Program (IDCRP) at the Uniformed Services University of the Health Sciences (USU) here and the University of Texas Health Science Center at San Antonio have published a patient outcome study in the March 30 online edition of Nature Medicine that may signal a need for a change of thought in the management of HIV.

3 Apr 2008

Gene mutations tied to immune comeback during therapy for HIV-1

A new study by U.S. scientists provides compelling evidence that two genes are linchpins in defining the course of immune restoration in HIV-positive individuals undergoing virus-suppressing therapy.

31 Mar 2008

Expansion of monocyte subset could serve as a biomarker for HIV progressions

An increase in the CD163+/CD16+ monocyte subset could be a biomarker for the progression of HIV disease, according to researchers at Temple University.

31 Mar 2008

Scientists discover how salmonella becomes lethal for AIDS patients

Nearly half of all HIV-positive African adults who become infected with Salmonella die from what otherwise would be a seven-day bout of diarrhea.

25 Mar 2008

Infection with a mutated HIV strain results in better survival

Persons infected with a mutated HIV strain, transmitted from those who have the genetic advantages to control the virus, results in improved survival according to a recent study by South African researchers.

24 Mar 2008

Nasal vaccine for smallpox protects animals against 77 times the potentially lethal dose of smallpox

Scientists at NanoBio Corporation and the University of Michigan have demonstrated their nasally delivered vaccinia vaccine can protect animals against 77 times the potentially lethal dose of smallpox, and without the safety risks of current vaccines for smallpox.

27 Feb 2008

Genomatix integrates genome-wide open chromatin from next generation sequencing

Genomatix Software GmbH, a Systems Biology company focussed on high quality annotation and the understanding of gene regulation, has begun showcasing its abilities in the analysis of data generated by Next Generation Sequencing (NGS) technology.

26 Feb 2008